MENU
TSHA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Taysha Gene Therapies (TSHA) Ownership - Who owns Taysha Gene Therapies?
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease... Show more
Profile
Industry
N/A
Address
3000 Pegasus Park Drive
Phone
+1 214 612-0000
Employees
52
Web
https://www.tayshagtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
693.06M
P/E Ratio
2.70
Total Cash
116.59M
Projected Growth
N/A
Total Debt
61.35M
Revenue
7.22M
Risk (Beta)
0.38
Dividend Yield
N/A
Total Cash/Share
0.45
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
TSHA
Capitalization
693M
P/E Ratio
2.70
Risk (Beta)
0.38
Dividend Yield
N/A
Total Cash
117M
Total Cash/Share
0.45
Total Debt
61.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
7.22M
ROE
N/A
Book Value
55.1M
P/B Ratio
12.59
Cash Flow
N/A
Earnings
-0.34
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
5.35
Current Revenue Per Employee
31534.25
Dividends Per Share - Security
N/A
EBITDA
-85.47M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-59.56
Shares Held By Institutions
327M
Shares Outstanding - Current
262M
Total Liabilities
83.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
53.179
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
3000 Pegasus Park Drive
Phone
+1 214 612-0000
Employees
52
Web
https://www.tayshagtx.com